Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.

Ferrari Bravo M, De Conca V, Devoto GL, Sironi M, Mele R, Fumagalli A, Rimassa P, Rossi G, Zampogna A, Sticchi C, Gabutti G; Medical Screening Program Group.

J Prev Med Hyg. 2012 Mar;53(1):37-43.

PMID:
22803318
2.

Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results.

Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, Rubeca T, Salvadori P, Visioli CB, Zappa M.

Eur J Cancer Prev. 2004 Feb;13(1):19-26.

PMID:
15075784
3.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
4.

Screening for colorectal cancer in Italy: 2005 survey.

Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, Sassoli de Bianchi P, Senore C, Sigillito A, Vettorazzi M, Visioli C.

Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):49-60.

5.

What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.

Ventura L, Zappa M, Carreras G, Ciatto S, Grazzini G.

Tumori. 2011 Sep-Oct;97(5):547-50. doi: 10.1700/989.10709.

6.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

PMID:
15741571
7.

Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.

Lisi D, Hassan C, Crespi M; AMOD Study Group.

Dig Liver Dis. 2010 May;42(5):371-6. doi: 10.1016/j.dld.2009.07.019. Epub 2009 Sep 10. Erratum in: Dig Liver Dis. 2012 Feb;44(2):182. Hassan, C Cesare [corrected to Hassan, Cesare].

PMID:
19747888
8.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
9.

Colorectal cancer screening by fecal occult blood testing: results of a population-based experience.

Grazzini G, Castiglione G, Isu A, Mantellini P, Rubeca T, Sani C, Turco P, Zappa M.

Tumori. 2000 Sep-Oct;86(5):384-8.

PMID:
11130566
10.

Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community.

Crotta S, Castiglione G, Grazzini G, Valle F, Mosconi S, Rosset R.

Eur J Gastroenterol Hepatol. 2004 Jan;16(1):33-7.

PMID:
15095850
11.

Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.

Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME.

Endoscopy. 2013;45(1):27-34. doi: 10.1055/s-0032-1325800. Epub 2012 Dec 19.

PMID:
23254404
12.

Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.

Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A.

Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.

PMID:
19307978
13.

Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.

Parente F, Marino B, DeVecchi N, Moretti R; Lecco Colorectal Cancer Screening Group, Ucci G, Tricomi P, Armellino A, Redaelli L, Bargiggia S, Cristofori E, Masala E, Tortorella F, Gattinoni A, Odinolfi F, Pirola ME.

Br J Surg. 2009 May;96(5):533-40. doi: 10.1002/bjs.6568.

PMID:
19358181
14.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
15.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
16.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
17.

Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).

Peris M, Espinàs JA, Muñoz L, Navarro M, Binefa G, Borràs JM; Catalan Colorectal Cancer Screening Pilot Programme Group.

J Med Screen. 2007;14(2):81-6.

PMID:
17626707
18.
19.

Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.

Grazzini G, Ciatto S, Cislaghi C, Castiglione G, Falcone M, Mantellini P, Zappa M; Working Group of Regional Reference Centre for Oncological Screening of Tuscany.

J Med Screen. 2008;15(4):175-81. doi: 10.1258/jms.2008.008032.

PMID:
19106257
20.

[Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].

Scintu F, Canalis C, Capra F, D'Alia G, Giordano M, Mocci P, Pisano M, Casula G.

Ann Ital Chir. 2000 Nov-Dec;71(6):693-9. Italian.

PMID:
11347322

Supplemental Content

Support Center